How does stem cell therapy help children with autism?

MSC therapy reduces neuroinflammation, modulates the immune system, and promotes neural connectivity. Over 500 children treated at our clinic, with 75% showing improvements in communication, social interaction, eye contact, and behavioral patterns.

At what age can a child receive stem cell therapy for autism?

Children as young as 2 years old can receive MSC therapy for autism. Earlier intervention typically yields better outcomes. Our medical team evaluates each child individually to determine the optimal treatment protocol.

How many sessions of stem cell therapy are needed for autism?

Most children undergo 1-2 initial sessions, with follow-up sessions recommended every 6-12 months. Each session includes IV infusion and/or intrathecal administration of 30-100 million MSCs depending on age and weight.

What improvements can be expected after stem cell therapy for autism?

Parents commonly report improvements in eye contact, speech development, social interaction, attention span, reduced repetitive behaviors, better sleep patterns, and improved digestive function within 1-6 months after treatment.

Is stem cell therapy for autism safe for children?

Yes. Our Wharton's jelly MSCs are immunologically privileged and well-tolerated in pediatric patients. We have treated over 500 children with an excellent safety profile and no serious adverse events reported.

Stem Cell Therapy for Cerebral Palsy (2026 Guide)

Research findings on mesenchymal stem cell treatments for cerebral palsy, including outcomes for motor function improvement, spasticity reduction, and enhanced quality of life for CP patients.

How MSC Therapy Addresses Cerebral Palsy

Cerebral palsy results from perinatal brain injury causing motor dysfunction, spasticity, and developmental delays. MSC therapy targets the neuroinflammatory processes that perpetuate brain damage and prevent recovery, while releasing neurotrophic factors that support neural repair and synaptogenesis.

Clinical Outcomes in CP Patients

Published clinical studies document improvements in Gross Motor Function Classification System (GMFCS) scores, muscle tone reduction, enhanced upper extremity function, speech development, and cognitive gains. Many families report improved mobility, daily living independence, and quality of life within 3-6 months. Earlier intervention (before age 7) generally yields better outcomes.

Treatment Protocol for Cerebral Palsy

CP patients typically receive 200-300 million Wharton's jelly MSCs via intravenous infusion combined with intrathecal administration for direct CNS access. Treatment is integrated with physiotherapy, occupational therapy, and speech therapy during the stay. Our 12-month follow-up tracks GMFCS scores, functional milestones, and quality-of-life indicators.

Frequently Asked Questions

How does stem cell therapy help children with autism?: MSC therapy reduces neuroinflammation, modulates the immune system, and promotes neural connectivity. Over 500 children treated at our clinic, with 75% showing improvements in communication, social interaction, eye contact, and behavioral patterns.
At what age can a child receive stem cell therapy for autism?: Children as young as 2 years old can receive MSC therapy for autism. Earlier intervention typically yields better outcomes. Our medical team evaluates each child individually to determine the optimal treatment protocol.
How many sessions of stem cell therapy are needed for autism?: Most children undergo 1-2 initial sessions, with follow-up sessions recommended every 6-12 months. Each session includes IV infusion and/or intrathecal administration of 30-100 million MSCs depending on age and weight.
What improvements can be expected after stem cell therapy for autism?: Parents commonly report improvements in eye contact, speech development, social interaction, attention span, reduced repetitive behaviors, better sleep patterns, and improved digestive function within 1-6 months after treatment.
Is stem cell therapy for autism safe for children?: Yes. Our Wharton's jelly MSCs are immunologically privileged and well-tolerated in pediatric patients. We have treated over 500 children with an excellent safety profile and no serious adverse events reported.

Part of Our Neurological Conditions Content Cluster

Neurological Conditions — Treatment Cluster

Pillar: stem cell therapy for neurological conditions in Istanbul

Research & guides: stem cell therapy for cerebral palsy research | MSC treatment for autism spectrum disorder | stem cell therapy for stroke recovery in Turkey | MSC treatment for spinal cord injury rehabilitation